Preetha Shridas1,2, Victoria P Noffsinger3,4, Andrea C Trumbauer3, Nancy R Webb3,5. 1. Saha Cardiovascular Research Center, University of Kentucky Medical Center, Lexington, KY, 40536, USA. pshri2@uky.edu. 2. Departments of Internal Medicine, University of Kentucky Medical Center, Lexington, KY, 40536, USA. pshri2@uky.edu. 3. Saha Cardiovascular Research Center, University of Kentucky Medical Center, Lexington, KY, 40536, USA. 4. Departments of Internal Medicine, University of Kentucky Medical Center, Lexington, KY, 40536, USA. 5. Pharmacology and Nutritional Sciences, Division of Nutritional Sciences, University of Kentucky Medical Center, Lexington, KY, 40536, USA.
Abstract
PURPOSE: Group X (GX) and group V (GV) secretory phospholipase A2 (sPLA2) potently release arachidonic acid (AA) from the plasma membrane of intact cells. We previously demonstrated that GX sPLA2 negatively regulates glucose-stimulated insulin secretion (GSIS) by a prostaglandin E2 (PGE2)-dependent mechanism. In this study we investigated whether GV sPLA2 similarly regulates GSIS. METHODS: GSIS and pancreatic islet-size were assessed in wild-type (WT) and GV sPLA2-knock out (GV KO) mice. GSIS was also assessed ex vivo in isolated islets and in vitro using MIN6 pancreatic beta cell lines with or without GV sPLA2 overexpression or silencing. RESULTS: GSIS was significantly decreased in islets isolated from GV KO mice compared to WT mice and in MIN6 cells with siRNA-mediated GV sPLA2 suppression. MIN6 cells overexpressing GV sPLA2 (MIN6-GV) showed a significant increase in GSIS compared to control cells. Though the amount of AA released into the media by MIN6-GV cells was significantly higher, PGE2 production was not enhanced or cAMP content decreased compared to control MIN6 cells. Surprisingly, GV KO mice exhibited a significant increase in plasma insulin levels following i.p. injection of glucose compared to WT mice. This increase in GSIS in GV KO mice was associated with a significant increase in pancreatic islet size and number of proliferating cells in β-islets compared to WT mice. CONCLUSIONS: Deficiency of GV sPLA2 results in diminished GSIS in isolated pancreatic beta-cells. However, the reduced GSIS in islets lacking GV sPLA2 appears to be compensated by increased islet mass in GV KO mice.
PURPOSE: Group X (GX) and group V (GV) secretory phospholipase A2 (sPLA2) potently release arachidonic acid (AA) from the plasma membrane of intact cells. We previously demonstrated that GX sPLA2 negatively regulates glucose-stimulated insulin secretion (GSIS) by a prostaglandin E2 (PGE2)-dependent mechanism. In this study we investigated whether GV sPLA2 similarly regulates GSIS. METHODS: GSIS and pancreatic islet-size were assessed in wild-type (WT) and GV sPLA2-knock out (GV KO) mice. GSIS was also assessed ex vivo in isolated islets and in vitro using MIN6pancreatic beta cell lines with or without GV sPLA2 overexpression or silencing. RESULTS: GSIS was significantly decreased in islets isolated from GV KO mice compared to WT mice and in MIN6 cells with siRNA-mediated GV sPLA2 suppression. MIN6 cells overexpressing GV sPLA2 (MIN6-GV) showed a significant increase in GSIS compared to control cells. Though the amount of AA released into the media by MIN6-GV cells was significantly higher, PGE2 production was not enhanced or cAMP content decreased compared to control MIN6 cells. Surprisingly, GV KO mice exhibited a significant increase in plasma insulin levels following i.p. injection of glucose compared to WT mice. This increase in GSIS in GV KO mice was associated with a significant increase in pancreatic islet size and number of proliferating cells in β-islets compared to WT mice. CONCLUSIONS: Deficiency of GV sPLA2 results in diminished GSIS in isolated pancreatic beta-cells. However, the reduced GSIS in islets lacking GV sPLA2 appears to be compensated by increased islet mass in GV KO mice.
Entities:
Keywords:
Arachidonic acid; GV sPLA2; Insulin secretion; Type 2 diabetes; β-islet mass
Authors: Robin Shoemaker; Frederique Yiannikouris; Sean Thatcher; Lisa Cassis Journal: Am J Physiol Endocrinol Metab Date: 2015-08-04 Impact factor: 4.310
Authors: Peter M Jones; Christopher J Burns; Véronique D Belin; Helen M Roderigo-Milne; Shanta J Persaud Journal: Diabetes Date: 2004-02 Impact factor: 9.461